Axim Biotechnologies, Inc (AXIM) financial statements (2022 and earlier)

Company profile

Business Address 6191 CORNERSTONE COURT, E
SAN DIEGO, CA 92121
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 4575121,8062,058713
Cash and cash equivalents 4575121,8062,058713
Receivables  32155 
Inventory, net of allowances, customer advances and progress billings  48810938
Inventory  48810938
Prepaid expense     41
Intangible current assets     63
Other undisclosed current assets 25631920241518
Total current assets: 7131,6392,0232,1131,374
Noncurrent Assets
Operating lease, right-of-use asset 131 
Property, plant and equipment 1042  12
Intangible assets, net (including goodwill) 2,45851   
Goodwill 2,458    
Intangible assets, net (excluding goodwill)  51   
Prepaid expense 5 77 
Other undisclosed noncurrent assets 7,799(2)546363
Total noncurrent assets: 10,49751617175
Other undisclosed assets 104269 
TOTAL ASSETS: 11,3141,6922,0892,1921,449
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 1,073775218442 
Other undisclosed accounts payable and accrued liabilities 1,073775218442 
Debt 3441,0521,4335,635758
Due to related parties  1,5271,6501,6061,619
Other liabilities 25422323 
Other undisclosed current liabilities 54   640
Total current liabilities: 1,4963,3953,3247,7053,017
Noncurrent Liabilities
Long-term debt and lease obligation     46
Long-term debt, excluding current maturities     46
Other undisclosed noncurrent liabilities 8,2525,0574,847772758
Total noncurrent liabilities: 8,2525,0574,847772804
Total liabilities: 9,7498,4528,1718,4773,821
Stockholders' equity
Stockholders' equity attributable to parent, including: 1,162(6,860)(6,164)(6,333)(2,372)
Common stock 136655
Common stock, share subscribed but unissued, subscriptions receivable (202)(50)(41)(24)(20)
Additional paid in capital 43,20128,62322,86415,92415,673
Accumulated deficit (41,850)(35,440)(28,992)(22,238)(18,070)
Other undisclosed stockholders' equity attributable to parent     40
Other undisclosed stockholders' equity 4041008248 
Total stockholders' equity: 1,566(6,760)(6,082)(6,284)(2,372)
TOTAL LIABILITIES AND EQUITY: 11,3141,6922,0892,1921,449

Income statement (P&L) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues  7991964847
Cost of revenue  (576)(9)(43)(154)
Cost of goods and services sold     (154)
Gross profit:  2241875(107)
Operating expenses (4,949)(6,729)(5,223)(3,154)(3,652)
Operating loss: (4,949)(6,506)(5,036)(3,149)(3,759)
Nonoperating income (expense) (1,342)58(1,719)(1,019)2,050
Investment income, nonoperating (86)(75)(1,123)(704) 
Interest and debt expense (1,158)(249)(140)(315)1,109
Loss from continuing operations before equity method investments, income taxes: (7,449)(6,696)(6,894)(4,483)(600)
Other undisclosed income (loss) from continuing operations before income taxes 1,158249140315(5,210)
Loss from continuing operations: (6,291)(6,448)(6,755)(4,168)(5,810)
Loss from discontinued operations (119)    
Net loss available to common stockholders, diluted: (6,410)(6,448)(6,755)(4,168)(5,810)

Comprehensive Income ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss: (6,410)(6,448)(6,755)(4,168)(5,810)
Comprehensive loss, net of tax, attributable to parent: (6,410)(6,448)(6,755)(4,168)(5,810)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: